Imagine a bill that would grant unprecedented immunity to product manufacturers who obtain the approval of any federal regulator. Multibillion-dollar companies would face virtually no accountability for the products they put on the market, so long as it was rubber-stamped by an understaffed government office first - no matter how much harm that product caused.
That was exactly the measure that was weighed here in North Carolina three years ago, pushed hard by the Pharmaceutical Research Manufacturers of America lobbyists.
Our Charlotte personal injury lawyers weren't the only ones relieved when it finally died in committee. However, it reared its ugly head again this spring in the form of Senate Bill 648. Once again, representatives from the PRMA were pushing it hard.